Development and Characterization of a Cocrystal as a Viable Solid Form for an Active Pharmaceutical Ingredient
Soojin Kim(Boehringer Ingelheim (Japan)), Chris H. Senanayake(Boehringer Ingelheim (United States)), John A. Smoliga(Boehringer Ingelheim (Germany)), Jonathan T. Reeves(Boehringer Ingelheim (Japan)), Herbert Nar(Boehringer Ingelheim (Germany)), Yin‐Chao Tseng(Boehringer Ingelheim (Germany)), Earl Spinelli(Boehringer Ingelheim (Japan)), Zhibin Li(Boehringer Ingelheim (Japan)), Hee‐Won Lee(Boehringer Ingelheim (Japan)), Nathan K. Yee(Boehringer Ingelheim (Japan)), Jinhua J. Song(Boehringer Ingelheim (Japan)), Richard J. Varsolona(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 17
Related Papers
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383